CVS HEALTH Corp — Director's Dealing 2021

Apr 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-02-01

Reporting Person: Bisaccia Lisa (Former EVP & Chief HR Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	A	77457	—	Acquired	100103	Direct
2021-04-01	Common Stock	F	35120	$74.30	Disposed	64983	Direct
2021-04-01	Common Stock	F	1190	$74.30	Disposed	66417	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23942	Indirect
Common Stock (restricted)	3523	Direct
ESOP Common Stock	655	Indirect
Stock Unit	32145.773	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Phantom Stock Credits	$1.00		Common Stock (469.0358)	469.0358	Direct
Stock Option	$102.26	2022-04-01	Common Stock (34241)	34241	Direct
Stock Option	$104.82	2023-04-01	Common Stock (39433)	39433	Direct
Stock Option	$78.05	2024-04-03	Common Stock (55098)	55098	Direct
Stock Option	$62.21	2025-04-01	Common Stock (64222)	64222	Direct
Stock Option	$54.19	2029-04-01	Common Stock (141405)	141405	Direct
Stock Option	$58.34	2030-04-01	Common Stock (98558)	98558	Direct

Footnotes

F1: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

F2: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.

F3: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.

F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F5: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F7: Option became exercisable in four equal annual installments, commencing 4/1/2017.

F8: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F10: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F11: The number of shares subject to the option were calculated using a 30-day average price.

F12: Options became exercisable in four equal annual installments, commencing 4/1/2021.